Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
AIDS Research and Human Retroviruses|January 19, 2012
Primary drug resistance in South Africa: data from 10 years of surveysJusten Manasa, David Katzenstein, Sharon Cassol, et al.
Journal of the International AIDS Society|February 9, 2024
Body weight and blood pressure changes on dolutegravir-, efavirenz- or atazanavir-based antiretroviral therapy in Zimbabwe: a longitudinal studyTinei Shamu, Matthias Egger, Tinashe Mudzviti, et al.
Plos One|February 23, 2024
Virologic outcomes on dolutegravir-, atazanavir-, or efavirenz-based ART in urban Zimbabwe: A longitudinal studyTinei Shamu, Matthias Egger, Tinashe Mudzviti, et al.
Pediatric Health, Medicine and Therapeutics|December 25, 2023
A Scoping Review of Gut Microbiome and <i>Bifidobacterium</i> Research in Zimbabwe: Implications for Future StudiesDanai T Zhou, Taona E Mudhluli, Lindsay J Hall, et al.
JCO Global Oncology|August 14, 2020
Prevalence and Subtype Distribution of High-Risk Human Papillomavirus Among Women Presenting for Cervical Cancer Screening at Karanda Mission HospitalPaul Thistle, Rabea Parpia, Debanjan Pain, et al.
Southern African Journal of HIV Medicine|May 10, 2024
Effect of dolutegravir on ferritin, iron, and C-reactive protein among people living with HIV and co-infectionsBridget Kamurai, Raylton P Chikwati, Donald Vhanda, et al.
Oncology Reviews|May 6, 2024
Still Far to Go With Characterisation of Molecular and Genetic Features of Diffuse Large B-Cell Lymphoma in People Living With HIV: A Scoping ReviewMaudy C P Manyau, Blessing Zambuko, Moses Chatambudza, et al.
The Pan African Medical Journal|January 21, 2022
An analysis of the COVID-19 laboratory dataset at AiBST Laboratory in Harare, Zimbabwe, 2020Tendai Chipendo, Takudzwa Marembo, Humphrey Chituri, et al.
Viruses|October 29, 2025
Pan-Resistant HIV-1 Drug Resistance Among Highly Treated Patients with Virological Failure on Dolutegravir-Based Antiretroviral Therapy in ZimbabweTendai Washaya, Benjamin Chimukangara, Justin Mayini, et al.
Virology Journal|March 15, 2026
Leveraging the Oxford Nanopore MinION sequencing platform for HIV-1 drug resistance surveillance in resource-limited settings: a post-COVID implementation opportunityTendai Washaya, Benjamin Chimukangara, Justin Mayini, et al.
Pageof 7